Sareum Share News (SAR)

Sareum Holdings Up As CEO Gets Ready To Present At Partnering Conference

LONDON MIDDAY BRIEFING: Morrison Sales Continue To Decline

WINNERS & LOSERS: Morrisons Sales Decline Sinks Shares

Sareum Says Equity Swap Deal With YA Global Master Ends Early (ALLISS)

Sareum Cautiously Optimistic As It Posts Widened First Half Loss

Sareum Gets Further US Patent Protection For Kinase Inhibitors

Sareum Granted European Patent For Kinase Inhibitor Compounds

Sareum Holdings Sees Widened Loss As It Focuses On Commercialisation

Sareum reports progress with psoriasis drug development programme

Drug development firm Sareum and its partner SRI International have reported progress with its drug development programme for the autoimmune disease psoriasis. Psoriasis can occur when the production of cytokines is not properly regulated and immune cells are consequently overly activated. The cyct

Sareum Sees "Promising Step" In Potential Psoriasis Drug

Sareum Granted EU Patent For CHKI Cancer Programme Invention

Sareum Holdings Granted Japanese Patent For Kinase Inhibitors

Sareum Holdings Raises New Money From YA Global Master

LONDON (Alliance News) - Sareum Holdings PLC Friday said it has raised GBP550,000 through a new placing and equity swap with YA Global Master SPV Ltd, money it will use for working capital and to fund its main research programmes. The specialist cancer drug company said YA Global Master ha

UK MIDDAY BRIEFING: ITV Punished For Not Paying Out More

LONDON (Alliance News) - ITV reported higher profits and revenues for 2013 and gave a bullish outlook for 2014, but has seen its shares punished Wednesday after it failed to increase its special dividend. The television company raised its total dividend for 2013 to 3.5 pence, from 2.6 pence

UK WINNERS & LOSERS: Contrarian Price Moves For ITV And Weir Shares

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Weir Group, up 6.5%. Despite reporting a fall in profit and revenue fo